Short Communicationp. 236-239

Impact of a clinical pharmacist in a multidisciplinary consultation on the switch to a biosimilar for inflammatory rheumatic diseases

Author(s): Xian Chao Wang

DOI: 10.37532/1758-4272.2023.18(8).236-239

• Abstract
• Full-Text
• PDF

Review Articlep. 203-206

Disease Activity and Colchicine Resistance in Familial Mediterranean Fever: Gene Variants' Influence

Author(s): Hounzou C

DOI: 10.37532/1758-4272.2023.18(8).203-206

• Abstract
• Full-Text
• PDF

Opinion Articlep. 211-215

A Review of Ant phospholipid Syndrome

Author(s): Zhiang Chao

DOI: 10.37532/1758-4272.2023.18(8).211-215

• Abstract
• Full-Text
• PDF

Short Communication

Ankylosing Spondylitis and Systemic Lupus Erythematosus: A Rare Coexistence

Author(s): Xaria Cobin

DOI: 10.37532/1758-4272.2023.18(8).215-219

• Abstract
• Full-Text
• PDF

Review Articlep. 220-223

Epidemiology of Systemic Lupus Erythematosus: Prevalence, Incidence, and Risk Factors

Author(s): Lahim Imran

DOI: 10.37532/1758-4272.2023.18(8).220-223

• Abstract
• Full-Text
• PDF

Commentaryp. 227-230

Exploring Rheumatologist Perspectives on Therapy Options for COVID-19

Author(s): Dimitris Sikivi

DOI: 10.37532/1758-4272.2023.18(8).227-230

• Abstract
• Full-Text
• PDF

Commentaryp. 231-235

Extracorporeal Shock Wave Therapy: A Non-Invasive Treatment Approach for Various Conditions

Author(s): Doria Andrea

DOI: 10.37532/1758-4272.2023.18(8).231-235

• Abstract
• Full-Text
• PDF

Commentaryp. 207-210

A brief Review of Rheumatoid Arthritis Pain Assessment Scale

Author(s): Susant Kumar

DOI: 10.37532/1758-4272.2023.18(8).207-210

• Abstract
• Full-Text
• PDF

Short Communicationp. 240-244

Regulation of Gene Expression by miR-21

Author(s): Zihadul Hakim

DOI: 10.37532/1758-4272.2023.18(8).240-244

• Abstract
• Full-Text
• PDF

Editorialp. 224-226

Exchanging among rheumatologists' view of non-clinical custom and Bio-similar biologics

Author(s): Ramchanra Yadav

DOI: 10.37532/1758-4272.2023.18(8).224-226

• Abstract
• Full-Text
• PDF